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INTRODUCTION
Vascular access using a central venous catheter has become an essential component of modern medical care (1) . The majority of venous access procedures were historically performed by surgeons (2) . However, with the benefit of sonographic and fluoroscopic guidance, interventional radiologists have been safety performing the placement of central venous catheters (3) . Several studies have reported a high technical success rate and a low complication rate for tunneled-catheter insertion via the internal jugular vein (IJV) using sonographic and fluoroscopic guidance (4) (5) (6) (7) (8) . However, to our knowledge, there have been no reports comparing the outcomes of tunneled-cuffed catheter insertions among patients with different underlying diseases, such as kidney or hematologic disorders.
The aim of this study was to evaluate the outcome of tunneled-cuffed catheter insertions placed radiologically via the IJV in patients with different types of underlying disorders.
patency. The right IJV was preferred as the initial access route because it has a straight course and facilitates catheterization (9) .
The left IJV was chosen in 185 cases because of right mastectomy, right chest wall radiation therapy, venous thrombosis on ultrasound, or the presence of a right-sided catheter.
The access site was initially prepared and draped using standard surgical techniques with betadine solution. All procedures were performed in a routine manner using ultrasound and fluo- Table 1 . This retrospective study was approved by the Institutional Review Board at our institution.
MATERIALS AND METHODS

Study Populations
The indications for catheter placement were hemodialysis, chemotherapy, plasmapheresis, total parenteral nutrition, and administration of intravenous medications or blood products. The blood cell counts, including the white blood cell (WBC) and platelet counts, were obtained in all patients on the day of the procedure to evaluate the correlation between infection and the WBC count, and between thrombotic dysfunction, hemorrhage, or venous thrombosis and the platelet count.
Procedure
All of the procedures were performed in an interventional radiology suite, and written informed consent was obtained from the patients prior to the procedure. Antibiotic prophylaxis is not used routinely in our institute. If the patient was uncooperative, a sedative (2.5 mg of midazolam initially in adults, up to 5 mg; 0.1 mg/kg of midazolam or 0.01 cc/kg of ketamine in children) was administered intravenously, and the doctor maintained a close watch on the patient. All patients were monitored with a pulse oximeter, electrocardiography, and noninvasive blood pressure cuffs.
An examination of the IJV was performed prior to skin preparation using ultrasound in order to evaluate the vessel size and 
Definitions
Technical success was defined as the catheter tip placed precisely at the correct location (at the right atrium or cavoatrial Chest posteroanterior radiograph obtained 6 months after catheter placement. The catheter is migrated and its tip is located at the clavicle level (arrow). The catheter had been removed on that day, and re-inserted on the following day. Catheter migration occurred in 10 insertions (0.47%, 0.049/ 1000 catheter days; mean, 58.22; range, 3-178 days). These were handled by catheter reposition (n = 2), catheter exchange (n = 2), and catheter removal (n = 6). Catheter kinking occurred in 5 insertions (0.23%, 0.024/1000 catheter days) and was an early complication (mean, 12.40; range, 1-27 days). These were handled by catheter reposition (n = 2), catheter exchange (n = 1), and catheter removal (n = 2). Three of these catheters were kinked on the initial chest radiograph after catheter insertion.
Of the 185 complications, 86 (11.65%) occurred in patients with hematologic disease; 96 (7.17%), in patients in renal failure; and 3 (5.08%), in patients with solid tumors (Table 3) range, 1-6 days). These were handled by catheter removal (n = 4) and additional suturing of the incision sites (n = 21). Venous thrombosis occurred in 7 insertions (0.33%, 0.034/1000 catheter days) and tended to develop later (mean, 137.00; range, 11-267 Table 6 . Significant differences in the platelet counts but not the WBC counts were found between patients with different underlying diseases (p = 0.000 and p = 0.298, respectively). Tables 7 and 8 
DISCUSSION
In the present study, we successfully inserted 2148 catheters and achieved a technical success rate of 99.77%. A total of 185 complications occurred, resulting in a complication rate of 8.61%. However, we achieved an extremely low incidence of procedure-retious complication rates and incidence of hemorrhaging differed significantly between these 2 groups (9.61% vs. 3.26%, p = 0.000; 0.13% vs. 1.79%, p = 0.000, respectively) ( Table 3) . However, no significant relationship was found between hemorrhaging and the platelet count in the renal failure group (p = 0.012, odds ratio: 0.993).
A total of 1968 catheter insertions were achieved via the right IJV, whereas 180 catheter insertions were achieved via the left IJV.
No significant differences were observed between the access routes and the overall complication rates (p = 0.487) ( Table 5 ). However, significant differences were found between the access routes and thrombotic dysfunction (right, 0.81%; left, 2.70%; p = 0.029).
The mean platelet and WBC counts at the time of catheter insertion were 1678200/mm 3 and 11900/mm 3 , respectively. The blood cell counts according to the underlying diseases are sum- (16) . The present results were similar to those of this previous report but were slightly lower (9.61%, 71 cases in 738 insertions).
In the present study, the CRI rates differed significantly between patients with hematologic diseases and those with other diseases. However, no significant differences in the incidence of (7) reported a catheter thrombosis rate of 6.7% (0.16/100 catheter days). Hence, the incidence of catheter thrombosis in the present study is lower than that in the previous one. Significant differences were found between the right and left venous approaches, but the basis of this difference remains unclear.
Wong et al. (25) However, the platelet counts did not reflect the transfused platelet concentrate. Hence, further study will be needed to address the relationship between platelet count and incidence of complications.
This study had several limitations. First, we retrospectively reviewed the medical records, including physicians' progress notes and nurses' notes; however, some data might have been omitted from these medical records. Moreover, because of the lack of medical records, we were unable to evaluate periprocedural complications. Second, the solid tumor group and the one designated "others" had significantly fewer patients than the hematologic and renal failure groups. Similarly, the left IJV approach involved underlying diseases.
Persistent bleeding was the second most common complication in our study. In total, 25 cases of persistent bleeding required hemostasis or catheter removal. Of these, 24 and 1 occurred in the renal failure and hematologic groups, respectively, and the incidence of this complication significantly differed between them. Importantly, a significant relationship was found between platelet count and hemorrhaging in the renal failure group. Paradoxically, the platelet count in the renal failure group was more than that in the hematologic group. Because most of the hematologic patients underwent catheter placement routinely for chemotherapy, these patients may have been corrected for abnormal conditions before the procedure. However, one third of the renal failure patients had acute kidney injuries, an urgent condition, which may have resulted in undergoing catheter placement before the correction of abnormal conditions. Moreover, many of the renal failure patients had other underlying systemic diseases (e.g., diabetes). As is well known, acute and chronic renal failure patients have bleeding diathesis, which is considered to be a multifactorial condition (17) . Many authors consider hemorrhage in renal failure patients to be an inevitable result of poor platelet function rather than a complication of the procedure (18). Obialo et al. (19) reported a high incidence, 42%, for the hemorrhagic complication rate in renal failure patients. Based on these previous and present findings, hemorrhagic complications might occur more frequently in renal failure patients than in hematologic disease patients.
Central venous catheter-related venous thrombosis occurred only in the hematologic patients and was observed at a relatively high frequency in this group. Six of the 7 patients with this complication had symptoms such as facial, neck, or arm swelling.
The remaining patient had no symptoms, as the venous thrombosis was found incidentally by a follow-up chest CT. Several previous studies have reported central venous catheter-related thrombosis occurring at an incidence of 1.2-34.1% in hematologic patients (20) (21) (22) (23) . Our study results were similar to these previous findings. Tesselaar et al. (24) reported the risk of venous thrombosis was 3.5-fold higher for left-sided compared to right-sided placement. However, in our study, no significant relationship was found between the left-and right-sided placements.
Catheter malfunction (e.g., catheter thrombosis) occurred in In summary, a very high technical success rate and very low procedure-related complication rate were achieved. Hematologic patients had a somewhat higher complication rate than other patients, and infection represented the most frequent and challenging complication in the study population. Particular attention should be focused on hematological patients to reduce complications. In conclusion, the tunneled-cuffed catheter insertion placed radiologically via IJV is safe and effective in patients with various underlying diseases.
